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Interspecies Extrapolation in
Carcinogenesis: Prediction Between Rats
and Mice
by Lois Swirsky Gold,* Leslie Bernstein,t Renae Magaw,*
and Thomas H. Slone*
Interspecies extrapolation in carcinogenesis is studied byevaluating prediction from rats to mice and from
mice to rats. The Carcinogenic PotencyDatabase, which includes 3500 cancer tests conducted in rats ormice
on 955 compounds, is used for the analysis. About halfofthe chemicals tested forcarcinogenicity are posi-
tive in at least one test, and this proportion is similar when rats and mice are consideredseparately. For392
chemicals tested in both species, 76% ofthe ratcarcinogens arepositive in the mouse, and70%o ofmouse car-
cinogens are positive in the rat. When compounds composed solely ofchlorine, carbon, hydrogen, and, op-
tionally, oxygen are excluded from the analysis, 75% ofmousecarcinogens arepositivein the rat. Overall con-
cordance (the percentage positive in both species plus thepercentage negative in both) is 76%. Three factors
that affect prediction between rats and mice are discussed: chemical class, mutagenicity in the Salmonella
assay, and the dose level at which a chemical is toxic. Prediction is more accurate for mutagens than non-
mutagens andforsubstances that are toxic at low (versusonly athigh) doses. Species differences are notthe
result offailure in the bioassay to attain the maximum tolerated dose in the negative species orofmore fre-
quent testing in thepositive species. An analysis ofthepredictive value ofpositivity forthe 10 mostcommon
target sites indicates that most sites are goodpredictors ofcarcinogenicity at some site in the otherspecies;
the poorest predictors among these common sites are the rat urinary bladder and the mouse liver.
Introduction
Epidemiologic data on chemically induced cancer in hu-
mans are difficult to obtain, and only 50 chemicals and
manufacturing processes have been evaluated by the In-
ternational Agency for Research on Cancer (IARC) as
having sufficient evidence of carcinogenicity in humans
(1). In the absence of evidence in humans, chronic-
exposure experiments are conducted in rodents, andposi-
tive results are used to predict the chemicals that may
present a cancer risk to humans. This paper examines ex-
trapolation between species by determining how well one
can predict carcinogenicity from a rat to a mouse orfrom
a mouse to arat. Ifthe carcinogenic response in these two
closely related species does not agree, then confidence in
extrapolation from rodents to humans (two very different
species) may be weakened; conversely, if there is good
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agreementbetweenrodent species, then confidence may
be strengthened.
In a study ofinterspecies extrapolation in carcinogen-
esis, results can be presented qualitatively (positive for
carcinogenicity vs. not positive), as well as quantitatively,
usingthe carcinogenicpotencyofthe compound(the dose-
rate that induces tumors in a predetermined proportion
ofexperimental animals). In an earlier paper(2), we dis-
cussed the good correlation of carcinogenic potency be-
tween rats and mice and showed that the interpretation
of this correlation is made difficult by an artifact of
potency estimation. In this paper we investigate the
qualitative response in rats vs. mice using the largest
available database ofthe results ofchronic-exposure ro-
dent experiments, the Carcinogenic Potency Database
[CPDB] (3-5).
While it is possible to assess the sensitivity ofrodent
bioassays to detect human carcinogens, it is not possible
to assess directly whether rodent carcinogens (ofwhich
there are hundreds)have any substantial carcinogenicef-
fect on humans. Many researchers are skeptical of ex-
trapolatingriskfrom rodents to humans (6,7). Tb provide
clues about species extrapolationusingrats andmice, weGOLD ETAL.
first describe the proportion oftest agents that have been
shown to induce tumors in each species and the relative
frequency of each target site. Second, we assess the
predictive values of carcinogenicity in one species for
results in the other, and we consider three factors that
might affect species extrapolation: chemical class,
mutagenicity of the compound, and dose level at which
the chemical is toxic. Third, we determine whether some
target organs are better predictors of a carcinogenic ef-
fect in the other species than are other target organs.
Methods
Ouranalyses are based onthe chemicals reported in the
CPDB (3-5), which is fully described in Gold et al. (3). The
database includes results for 3500 rat or mouse experi-
ments on955 compounds obtained from papers published
in the general literature through 1984 and from the Na-
tional Cancer Institute/National Ibxicology Program
(NCI/NTP) Technical Reports published through May
1986. All experiments in the database meet a specific set
ofinclusion criteria that are designed to permit the esti-
mation ofcarcinogenic potency; therefore, reasonable con-
sistency of experimental protocols is assured. Rodent
bioassays are included in the database only if the test
agent was administered alone, ratherthanin combination
with other substances; ifthe bioassay included a control
group; ifthe route ofadministration was either diet, wa-
ter, gavage, inhalation, IV injection or IP injection; and
ifthe length ofexperiment was at least 1 year with dos-
ingfor atleast6months. Forthe CPDB, we do not evalu-
ate the evidence for carcinogenicity in an experiment;
rather, we report the evaluation ofthe published author
and calculate the statistical significance of the tumori-
genic dose response.
The CPDB includes data on 64% ofthe 224 substances
that have been evaluated by IARC has having sufficient
evidence for carcinogenicity in experimental animals (1).
Some agents are excluded from the CPDB because of
route of administration (some polycyclic aromatic
hydrocarbons and inorganic chemicals) and some because
they are chemical .mixtures or industrial processes.
In the following analyses, we classify the results of an
experiment as either positive ornegative on the basis of
the author's opinion in the published paper. In some cases
authors do not clearly state theirevaluation, and in some
NCI/NTP Technical Reports the evidence for carcinoge-
nicity is considered only suggestive; in our analyses we
considerthese experiments aslacking "clearevidence of
carcinogenicity" andclassify them asnegative. We use the
author's opinion to determine positivity because, in addi-
tion to statistical significance, it often takes into account
historical control rates for particular sites, survival and
latency, and/or dose response. Generally, the designation
by author's opinion corresponds well with the results of
statistical tests for the significance ofthe dose-response
effect (3). A two-tailed significance level of0.01 produces
the greatest consistency between author's opinion and
statistical significance of the dose-response effect, sug-
gesting that researchers generally follow stringent
statistical criteria for determining carcinogenicity.
Ofthe 3485 experiments in rats or mice in the CPDB,
only 5% are evaluated as positive by author's opinion
without a corresponding statistically significant result
(p 2 0.01), and 6% are notevaluated aspositive bythe au-
thor although the results for at least one target site are
statistically significant (p < 0.01). These percentages are
similarforrats andmice, andfor NCI/NTPandliterature
tests. Of the experiments evaluated as positive by
author's opinionthatfail to satisfyp < 0.01 criterion, 59%
satisfy a p < 0.05 criterion.
When comparing rats and mice, we report results by
chemical; however, the numberofexperiments perchem-
ical in the CPDB varies. The percentages ofchemicals in
the CPDB with one experiment, two experiments and
more than two experiments are 31, 51, and 18, respec-
tively, for rats and 13, 54, and 33, respectively, for mice.
A chemical is considered positive in a given species ifit
is positive in any single experiment in that species. Posi-
tive target sites are identified across experiments in a
species usingall results for achemical. Evaluations ofthe
histopathology associated with each target site are not
presentedbecause descriptions oftumorpathology vary
markedly over time and from paper to paper.
Results
Positivity and larget Sites for 955
Chemicals Tested in Rats or Mice
Table 1 summarizes the proportions ofchemicals posi-
tive by species and data source. Overall, approximately
one-half ofthe chemicals in the CPDB that were tested
in either rats or mice are positive in at least one experi-
ment. Mice appear to be slightly less sensitive than rats
in literature reports, butthe reverse is true forbioassays
ofthe NCI/NTP. Theproportions ofpositive chemicalsfor
the NCI/NTP are somewhat lower than the general liter-
ature, largelybecause wehaveclassifiedasnegativethose
NCI/NTP experiments having only suggestive evidence
Table 1. Proportion ofchemicals tested in rats or mice that are
classified as positivea in at least one experiment, by species and
reference source, Carcinogenic Potency Database.
Proportion Proportion Proportion
Reference carcinogenic carcinogenic carcinogenic
source in rats or mice (%) in rats (%) in mice (%)
NCI/NTP or
literatureb 489/955 (51%) 341/706 (48%) 278/645 (43%)
NCI/NTP 120/251 (48%) 84/245 (34%) 94/246 (38%)
Literature 390/771 (51%) 268/502 (53%) 195/444 (44%)
'A chemical is classified as positive ifthe author of at least one pub-
lished experiment has evaluated the compound as carcinogenic in that
species.
bNumber of chemicals in the NCI/NTP or literature does not equal
the sum of each source separately because some chemicals have been
reported by both sources.
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ofcarcinogenicity. When positivity is determined by the
statistical significance ofthe dose response (at least one
target site with p < 0.01) rather than by author's opin-
ion, there is greater consistency between the NCI/NTP
andthe literature in the proportion ofchemicalspositive
in each species (forrats, 42% NCI/NTPchemicals vs. 49%
literature chemicals positive; for mice 44% vs. 45% posi-
tive). This results from the fact that the NCI/NTPTech-
nical Reports more often evaluate results atthe 0.01 level
ofstatistical significance aslacking "clearevidence ofcar-
cinogenicity," whereas authors of general literature
papers more often evaluate results for rats at the 0.05
level as positive.
Table 2 reports positive target sites for rat and mouse
carcinogens. Twenty-seven sites are identified aspositive
target organs in the mouse and 30in the rat. Inboth spe-
cies, the liver is the most common target site. The second
most common sites are the mouselungand the rat mam-
mary gland. In the subset ofNCI/NTP bioassays, which
use an extensive standardized pathology protocol, the
most frequent sites are the same for each species, al-
though the raturinarybladderis identified asfrequently
as is the mammary gland.
Comparison of Positivity in Rats and Mice
for 392 Chemicals in Both Species
The carcinogenic response in rats and miceforall chem-
icals, by chemical class, and by mutagenicity is summa-
rized in Table 3. For the 392 chemicals, agreement (con-
cordance) in response between rats and mice is 76%
(296/392), i.e., 130 chemicalspositive inbothand 166nega-
tive in both. Based onpositivity rates in the entire data-
base(Table 1), we wouldexpectby chance alone that 43%
ofthechemicalsthatarecarcinogenicin ratswouldbe car-
cinogenic in mice, and conversely, that 48% ofthose car-
cinogenic in mice would be carcinogenic in rats. Theposi-
tive predictive values for each species among the 392
chemicals (Table3) are significantly betterthanwouldbe
expected due to chance (chi-square goodness-of-fit test
p < 0.0001): 76%(130/170)ofthe ratcarcinogens areposi-
tive in mice, and 70% (130/186) ofthe mouse carcinogens
arepositive in rats. Theprediction ofnegatives is also sig-
nificantly betterthan expected: 75% (166/222)for rats and
81%(166/206)formice(chi-squaregoodness-of-fit testp <
0.0001).
We have examinedpredictionbetween speciesby chem-
Table 2. Frequency ofpositive target sites for chemicals classified as positive by author's opinion.
Number positive at site (%)a
Target organ
Liver
Lung
Mammary gland
Vascular system
Stomach
Hematopoietic system
Kidney/ureter
Urinary bladder/urethra
Esophagus
Nasal cavity/nasal turbinates
Ear/Zymbal gland
Skin/subcutaneous tissue
Thyroid gland
Small intestine
Peritoneal cavity
Central nervous system
Oral cavity
Uterus
Large intestine
Pituitary gland
Adrenal gland
Clitoral gland
Preputial gland
Pancreas
Spleen
Harderian gland
Gall bladder
Ovary
Testes
Myocardium
Bone
Mesovarium
Prostate
Vagina
Chemicals evaluated as
carcinogenic in rats
(n = 341)
128 (38%)
27 (8%)
69 (20%)
22 (6%)
53 (16%)
34 (10%)
39 (11%)
34 (10%)
27 (8%)
26 (8%)
26 (8%)
24 (7%)
20 (6%)
19 (6%)
16 (5%)
13 (4%)
13 (4%)
11(3%)
11(3%)
6 (2%)
6 (2%)
6 (2%)
1
6 (2%)
6 (2%)
0
0
0
3
0
2
2
2
1
aPercentages are not given when fewer than 1% of the carcinogens were active at a given site.
Chemicals evaluated as
carcinogenic in mice
(n = 278)
157 (56%)
82 (29%)
13 (5%)
46 (17%)
33 (12%)
38 (14%)
11(4%)
11(4%)
6 (2%)
3(1%)
2
2
10 (4%)
3 (1%)
7 (3%)
2
1
5 (2%)
0
4 (1%)
4 (1%)
2
6 (2%)
0
0
5 (2%)
3(1%)
3 (1%)
1
2
0
0
0
0
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Table 3. Comparison ofcarcinogenic response in rats and mice, by chemical class.a
Proportion of R+ Proportion of M +
R+M+ R+M- R-M+ R-M- that are also M+ that are also R +
Chemical classb (n) (a) (b) (c) (d) [a/(a+b)] [a/(a+c)]
All chemicals (392) 130 40 56 166 76% 70%
Aromatic amines (65) 30 5 14 16 86% 68%
Halogenated compounds
Chlorinated compoundsc (50) 18 0 19 13 100% 49%
Other halogenated compounds (23) 13 1 1 8 93% 93%
Miscellaneous aromatics and aliphatics (47) 11 9 4 23 55% 73%
Miscellaneous carbamates and ureas (37) 5 7 2 23 42% 71%
Miscellaneous heterocycles (36) 12 2 3 19 86% 80%
Nitro aromatics and heterocycles (34) 15 2 9 8 88% 63%
Miscellaneous esters and epoxides (31) 6 2 3 20 75% 67%
Azo compounds (18) 5 5 0 8 50% 100%
Inorganic substances (17) 2 1 0 14 67% 100%
Miscellaneous nitrogen compounds, hydrazines, etc. (17) 7 5 1 4 58% 88%
Mixtures or unidentified structures (10) 0 0 0 10
Nitroso compounds (7) 6 1 0 0 86% 100%
Salmonella results
Mutagens (138) 64 19 16 39 77% 80%
Nonmutagens (156) 34 16 29 77 68% 54%
aAmongthe 392 chemicals tested in both rats (R) and mice (M), 177 were reported only by NCI/NTP, 150 were reported only in the literature, and
65 were reported by both sources. Four chemicals reported in Table 1 that were tested in both species are not included here because negative results
in one species were based solely on a histological exam restricted to only 1 or 2 tissues.
bChemical classes are ordered by the total number of chemicals in the class. Each chemical is reported in only one class.
cCompounds composed solely of chlorine, carbon, hydrogen, and optionally, oxygen.
ical class (Table 3), but smallnumbers within mostclasses
prevent detailed, class-specific analyses. Results are most
striking for compounds composed solely ofchlorine, car-
bon, hydrogen, and, optionally, oxygen (hereafter, chlori-
nated compounds): 37/50(74%) are positive; the predictive
value of positivity in rats for positivity in mice is 100%
(18/18), compared to only 49% (18/37) from mice to rats.
When these chlorinated compounds are eliminated from
the set ofchemicals tested in both species, thepredictive
value ofpositivity from mice to rats is as accurate as that
from rats to mice (75%).
Prediction between species is also evaluated on the ba-
sis ofthe mutagenicity ofthe chemical (Table 3). We ob-
tained evaluations ofmutagenicity in Salmonella from re-
cent compilations for 294 of the 392 chemicals in the
CPDB that have been tested in both rats and mice (8,9;
E. Zeiger, personal communication, 1987). A chemical is
classified as mutagenic ifit is evaluated as positive in any
ofthe sources, and equivocal evaluations are considered
as negative. The overall concordance in carcinogenic re-
sponse between rats andmice forthis subset of294 chem-
icals is comparable to the larger set of392 substances. Ta-
ble 3 indicates that agreaterproportion ofmutagens are
carcinogenic than nonmutagens (72% vs. 51%, chi-square
p < 0.0001); additionally, a large proportion of carcino-
gens is not mutagenic (79/178, 44%). A similar result has
been reported elsewhere (9).
We would expect that chemicals capable of damaging
DNAmightbe more consistently positive across species
than chemicals acting by some other mechanism of car-
cinogenesis. The results in Table 3 provide some support
for this hypothesis. Prediction from mouse to rat is sig-
nificantly more accurate for mutagens (64/80, 80%) than
nonmutagens (34/63, 54%, chi-square p = 0.001). However,
forprediction from rat to mouse the difference is smaller
and not significant: 64/83 (77%) for mutagens vs. 34/50
(68%) for nonmutagens (chi-square p = 0.248). Because
chlorinated carcinogens are all positive in the mouse and
Table 4. Predictive value of carcinogenicity in one species for carcinogenicity in the other, by high dose administered in a bioassay.a
Rat carcinogens, Proportion of rat Mouse carcinogens, Proportion of mouse
high dose in rats, carcinogens that are high dose in mice, carcinogens that are
mg/kg/day positive in mice,* (%) mg/kg/day positive in rats, (%)
< 1 15/16 (94%) < 1 8/8 (100%)
1-10 23/25 (92%) 1-10 22/27 (81%)
10-100 55/72 (76%) 10-100 35/48 (73%)
100-1000 33/45 (73%) 100-1000 46/71 (65%)
> 1000 4/12 (33%) > 1000 19/32 (59%)
Total 130/170 (76%) 130/186 (70%)
aHigh dose administered in a positive experiment expressed as the daily dose rate in milligrams/kilogramaveraged over the duration ofthe test.
When the CPDB contained more than one positive experiment for a chemical in a species, the high dose rate chosen was from the experiment with
the most significant dose-response effect.
*p= 0.0003, test for trend.
tp = 0.008, test for trend.
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are not detected as mutagens, they inflate the predictive
value from rat to mouse for nonmutagens. Excluding
these chlorinated carcinogens, there is a greater differ-
ence between mutagens and nonmutagens in prediction
from rats to mice: for mutagens 61/80 (76%) and for non-
mutagens 23/39 (59%), (chi-square p = 0.052).
A further question related to species extrapolation in
carcinogenicity is whether chemicals that are toxic at
lower doses are more accurate predictors ofcarcinogenic-
ityinthe second species thanchemicals that are toxiconly
at higher doses. Since, in the standard chronic bioassay,
test animals generally are administered a dose that ap-
proximates the maximum tolerated dose (MTD), the high
dose in a bioassay may be used as a surrogate for the
chronic toxicity level ofeach chemical. Table 4reports the
proportion of rat carcinogens that are positive in the
mouse by the magnitude of the high dose administered
to rats; parallel data are given for mouse carcinogens.
There is a significant association between the high dose
level of acarcinogen used in one species and the likelihood
that itproduces a carcinogenic response in the other spe-
cies. The dose-related trend (10) is statistically significant
bothforprediction from rats to mice (n = 170, Mantel test
fortrend, p = 0.003) andfrom mice to rats(n = 186, Man-
tel test for trend, p = 0.008). Thus, carcinogens that are
toxic at lower doses in a species are better predictors of
carcinogenicity in the other species than are less toxic car-
cinogens.
A possible confounding factor in this significant trend
is mutagenicity: since predictive values are more accurate
for mutagens than nonmutagens (Table 3), ifcarcinogens
that are toxic atlow doses are also more likely to be muta-
gens, the association between toxic level and predictive
value may be a reflection ofmutagenicity. We examined
the association between mutagenic response and ad-
ministered dose level in positive rodent tests and found
that more toxic carcinogens are significantly more likely
to be mutagenic than less toxic carcinogens. Even after
adjusting for mutagenicity, however, the dose-related
trend in predictive value remains statistically significant
from rats tomice (n = 133, p = 0.008). The adjusted trend
predicting from mice to rats is statistically significant
when chlorinated compounds are excluded from the set
ofchemicals used (n = 110, p = 0.007), but is not statisti-
cally significant when all compounds are considered
(n =143,p = 0.116).
Predictive Value of 10 Frequent ¶Yarget
Sites
Tb compare extrapolation based on various target or-
gans, we have examined the predictive value ofindividual
target sites in one species for positivity at the same or
another site in the second species. Tomatis et al. (11)
earlierinvestigated thepredictive value ofthe mouse liver
for positivity in the rat using 51 carcinogens, and Ward
et al. (12) conducted a similar analysis for 85 mouse liver
carcinogens. For the 226 positive chemicals in our data-
base tested in both species, there are 10 sites that have
been evaluated as target organs for more than 15 chemi-
cals in either the rat or the mouse. In Table 5 we report
the number ofcompounds positive at each ofthese sites
for rats and mice; for each site, we also give the number
andproportion that are positive for any site in the second
species and the number ofchemicals that are positive at
the same site inboth species. Most sites are good predic-
tors ofcarcinogenicity at some site in the other species.
The least accurate predictors are the urinary bladder in
the rat (46%) and the liver in the mouse (63%). For each
species, about halfthe carcinogens are positive in at least
one ofthe same sites in the other species (87/170 for rats,
87/186 for mice).
Many chemicals cause tumors at more than one site in
a species. Multiple-site carcinogens in mice are more often
positive in rats than single-site carcinogens; this is not the
case when predicting from rats to mice. Eighty-two per-
cent (64/78) of the multiple-site mouse carcinogens are
positive in the rat compared to 61% (66/108) ofthe single-
site mouse carcinogens (chi-square p = 0.002). For rats,
Table 5. Predictive value of target sites in one species for carcinogenicity in a second species: rats and mice.
Rats Mice
Number positive Number positive
Tbtal number at site in rats Tbtal number at site in mice Number positive
positive at also positive at some positive at also positive at some in same site in
Thrget siteb sitec site in mice (%) sitec site in rats (%) rat and mouse
Liver 71 64 (90%) 117 74 (63%) 50
Lung 13 11 (85%) 42 35 (83%) 6
Mammary gland 33 30 (91%) 8 8 (100%) 6
Hematopoietic system 17 12 (71%) 29 24 (83%) 9
Vascular system 12 10 (83%) 26 19 (73%) 5
Urinary bladder/urethra 24 11 (46%) 8 8 (100%) 4
Stomach 23 20 (87%) 19 17 (89%) 9
Kidney/ureter 23 17 (74%) 10 9 (90%) 7
Skin/subcutaneous tissue 18 15 (83%) 2 2 (100%) 1
Ear/Zymbal gland 16 16 (100%) 2 2 (100%) 2
At least one site 170 130 (76%) 186 130 (70%) 87
aFor chemicals that are tested in both rats and mice and evaluated as positive in at least one experiment.
bTarget sites are those affected by more than 15 chemicals in at least one species.
cNumbers add to more than total for "at least one site" because there is often more than one target site per chemical per species.
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78% (68/87) ofthe multiple-site carcinogens are positive
in the mouse compared to 75% (62/83) of the single site
carcinogens (chi-squarep = 0.595). Forthepoorestpredic-
tive organs in Table 5, the ratbladder andthe mouseliver,
prediction between species is more accurate when the
chemical induces tumors at another site as well.
Among compounds that are tested in both rats and
mice, itis not common forapositive result to occurinonly
one target organ ofone species. For only three sites are
more than 10% ofthe carcinogenspositive injust one site
ofone species [raturinarybladder38% (9/24), mouse liver
26% (31/117) and mouse hematopoietic system 14% (4/29)].
Liver. The liver is the most frequent site in rats and
mice as well as the mostfrequent site in commonbetween
them. Positivity in rat liver is highly predictive of posi-
tivity in the mouse liver(64/71, 90%), butthe mouse liver
is more weakly predictive ofpositivity in the rat(74/117,
63%). The lower predictive value of mouse liver for rat
carcinogenicity reflects in part the lowerpredictive value
of chlorinated chemicals as a class, and the fact chlori-
nated chemicals tend to induce liver tumors. There is a
significant difference between chlorinated chemicals and
all other chemicals in the predictive value of the mouse
liver: amongchlorinated compounds 45% (14/31) ofthose
positive inmouse liverarepositive intherat; amongother
compounds 70%o(60/86)ofthosepositiveinmouse liverare
positive in the rat (chi-square p = 0.015). (In the follow-
ing discussion, we will refer to chemicals that arepositive
in the mouse liver but not in any other mouse organ or
in the rat as "single-site mouse liver carcinogens.")
The frequency of single-site mouse liver carcinogens
and the fact that liver tumors occur spontaneously at high
rates in the B6C3F1 male has led to the suggestion that
carcinogenicity in the mouse livermay morelikelybe due
to promotion ofinitiated cells or spontaneous tumors than
to genotoxicity (9,12). We therefore examined whether
single-site mouse liver carcinogens are less often muta-
genic than other mouse liver carcinogens. For the 91
mouse liver carcinogens on which we have mutagenicity
data in Salmonella, the proportion that are mutagenic is
lower among single-site mouse liver carcinogens (32%,
8/25) than other mouse liver carcinogens (56%, 37/66 chi-
square p = 0.040). Importantly, however, there is no dif-
ference in the frequency of mutagenicity when chlori-
nated chemicals are analyzed separately from otherchem-
icals: among the chlorinated compounds, 1/13 (8%)
single-site mouse liver carcinogens are mutagenic com-
pared to 2/16(13%) ofothermouse-liver carcinogens (chi-
squarep = 0.672). Amongall othercompounds 7/12(58%)
single-site mouse liver carcinogens are mutagenic com-
pared to 35/50 (70%) other mouse liver carcinogens (chi-
square p = 0.438). With respect to the B6C3F1 mouse, we
have found that positive mouse liver results in the
NCI/NTPbioassays are similar to those ofother strains.
Among 10 NCI/NTP chemicals that are positive in the
B6C3F1 liver andtested in another strain, 7 arepositive
in the second strain as well. Among the 20 NCI/NTP
chemicals that are single-site mouse livercarcinogens, we
find no evidence that results are deviant for the male,
which has a higher and more variable spontaneous rate
ofhepatic tumors thanthefemale: 13 ofthe 20 chemicals
(65%) induce livertumors inboth sexes ofB6C3F1 mouse,
5 in the male only (25%) and 2 in the female only (10%).
Possible Artifacts in Species Differences of
Positivity
Species differences inpositivity mayreflect artifacts of
measurement. For the chemicals tested in NCI/NTP
bioassays that are positive in one species only (rat, n =
23; mouse, n = 35), we examined whether the MTD was
administered to the positive species more often than to
the negative, since a carcinogenic effect is less likely to
be detected at lower doses. We found that the MTD, de-
fined by significant weight-gain depression or the pres-
ence ofclinical signs oftoxicity as cited in the Technical
Reports, was usually attained and was obtained equally
often in the positive and the negative species.
We also considered the possibility that chemicals posi-
tive only in one species may have been tested more fre-
quently in the positive than in the negative species.
Among the 96 chemicals tested in both species but posi-
tive in only one (Thble 3), halfwere tested equally often
in the positive and negative species, and 10% were tested
more often in the negative species. Thus, attainment of
the MTD andfrequency oftesting do not accountforposi-
tive results in one species only.
Carcinogen Identification on the Basis of
Two vs. Four Sex-Species Group
The CPDB contains 159 chemicals that have been
tested inboth sexes ofrats andmice andhavebeen evalu-
ated as positive in at least one experiment. This large
numberpermits us to address the question ofhow many
carcinogens would have been identified by performing
tests in only two ofthe four sex-species groups. Thble 6
reports theproportion ofcarcinogens identified by all pos-
Tible 6. Predictive value of two sex-species groups for
carcinogens tested in both sexes of rats and mice.a
Sex-species
groups used
to identify
carcinogensb
MM, MR
FM, MR
MM,TR
FM, FR
FM, MM
FR, MR
All experiments
Number
identified as
carcinogenic at
least once,
n = 159'
146 (92%)
143 (90%)
141 (89%)
139 (87%)
131 (82%)
115 (72%)
NCI/NTP experiments
Number
identified as
carcinogenic at
least once,
n = 114C
104 (91%)
102 (89%)
98 (86%)
97 (85%)
92 (81%)
79 (69%)
aFor chemicals tested in both sexes ofrats and mice that were evalu-
ated as carcinogenic in at least one experiment.
bFM, female mice; MM, male mice; FR, female rats; MR, male rats.
cPercent indicates proportion that would be correctly identified as car-
cinogens using results only from experiments in the two sex-species
groups, considering as positive an evaluation ofcarcinogenicity in either
sex-species group.
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sible combinations oftwo sex-species groups for the 159
carcinogens. The findings are similar to those reported
elsewhere for NCI/NTP bioassays (13,14). Testing chem-
icals in one sex of each species would have resulted in
identification of 85 to 92% of the carcinogens that are
identified byusingfour sex-species groups. The greatest
number would have been identified on the basis of the
male mouse and the male rat. Prediction ofpositivity be-
tween the sexes within each species (80-85%) is better
thanpredictionbetweenspecies(66-76%). Thus, any com-
bination ofa single mouse test and a single rat test would
identify more -carcinogens than tests in both sexes of
either species. One implication ofthis high detection rate
oftwo groups rather than four is that use of an alterna-
tive bioassay design that uses one sex ofeach species may
not result inmissinglarge numbers ofrodent carcinogens.
Discussion
Overall Positivity Rate
Our analysis of experiments on 955 chemicals shows
that approximately half of the chemicals tested for car-
cinogenicity in rodents are positive in at least one test,
and this proportion is stable across several sets of data
(Table 1). The 50% positivity rate agrees with previous
results for small groups of chemicals reported by NCI,
NTP, and in the general literature (13-18). Additionally,
for the 294 chemicals that have been tested for both
mutagenicity in Salmonella andfor carcinogenicity in rats
and mice, we find that only 26% are neither carcinogens
nor mutagens (Table 3). Positivity rates are so high that
it is important to try to understand how representative
they mightbe oftheproportion ofall chemicals thatwould
be positive iftested in rodent bioassays orthe proportion
of all chemicals that are potential human carcinogens.
One possible explanation for the high proportion ofro-
dent carcinogens is publication bias, i.e., positive results
are more likely to be published than negative results.
However, all results are published for NCI/NTP bioas-
says, and the proportion ofpositive tests in this group of
chemicals is comparable to that ofchemicals reported in
the literature (Table 1). Another possibility is that more
suspicious chemicals are tested for carcinogenicity. For
example, chemicals structurally similar to known carcino-
gens or chemicals that have been shown to be mutagens
maybe selected more often. This is alikelybias since can-
cer testing is both expensive and time consuming, and it
is prudent to test suspicious compounds. On the other
hand, chemicals are selected for testing for several rea-
sons, includingthe extent ofhuman exposure, level ofpro-
duction, and scientific questions about carcinogenesis.
Moreover, while some chemical classes are more often car-
cinogenic in rodent bioassays than others [e.g., nitroso
compounds, aromatic amines, nitroaromatics, chlorinated
compounds (Table 3)], predictive capability is still imper-
fect. Forexample, most chemicals testedforcarcinogenic-
ity are synthetic compounds due to great concern that
these man-made chemicals maybe carcinogens. However,
the positivity rate in the CPDB for naturally occurring
chemicals that have been tested in both rats and mice is
also high, 31/68 (46%).
It hasbeen suggested that chemicals put on testin the
early years ofthe NCI bioassay program were selected
more on the basis ofchemical structure, while chemicals
testedmore recentlyby NCI or NTPhavebeen selected
more onthe basis ofthe extentofhuman exposure. Ifthis
were so, then one might expect the positivity rate to be
higher among the earlier chemicals. For the NCI/NTP
chemicals we compared positivity rates over time and
found no significant difference. AmongTechnical Reports
published before 1979, 51% (60/118) were positive com-
pared to45% (60/133)publishedin 1979 orlater. Similarly,
wefound no significant differences inpositivity rates over
time among chemicals in the general literature (exclud-
ingthe Innes et al. series discussed below). This suggests
that the high positivity rate for chemicals tested in ro-
dents cannot be explained on the basis ofthese selection
criteria.
One large series, of mouse experiments conducted by
Innes et al. (19,20) is often cited as evidence that the
proportion of rodent carcinogens is actually low among
tested substances (21). In this series, among 120 pesti-
cides and industrial chemicals tested in two mouse
strains, only 11 (9%) were evaluated as carcinogens. The
protocol forthisbattery oftests differsfromthat ofother
tests in the CPDB, and this may account for the lower
positivity rate. The Innes series included only 18animals
in the vehicle control group and 18 in a single dose group;
the animals were on test for only 18 months, which may
not have been an adequate duration to detect a positive
effect. (Note: only 16% ofthe other mouse experiments
in the CPDB were ofsuch short duration.) Amongthe 19
chemicals tested by the Innes group and by another lab-
oratory, the Innes dose was usuallylower(sometimes by
more than 10 times) than the highest dose administered
by others. Because a carcinogenic effect is less likely to
be detected at lower doses, these tests were more likely
to be negative. Thus, because ofexperimental design fac-
tors, the Innes battery appears to have lacked sensitiv-
ity to detect a carcinogenic effect.
Ourfindings thus suggest that in future testing a high
proportion of chemicals may prove to be carcinogens in
rodentbioassays. Previouslywe discussed that carcinoge-
nicity in a rodent bioassay may result from the promo-
tional effects oftoxicity when the MTD is administered
(22). At near-toxic doses, a) cell-killing may remove nor-
mal neighboring cells surrounding amutated cell, thereby
removing signals inhibiting growth. This would permit
the mutated cell to form a tumor; and b) chronic cell-
killing and induced reparative hyperplasia andmutagenic
oxidants from phagocytic cells may yield increased gene
expression and chance ofmutation or associated genetic
alteration. Such effects wouldbe expected to increase the
proportion ofpositive chemicals in tests conducted at the
MTD, but at low doses without cell killing we would ex-
pect the proportion ofpositives tobe lower. Thefindings
that about half of rodent carcinogens are not mutagens
suggests that positive bioassay results may be due, in
part, to acceleration ofthepromotional stepofcarcinogen-
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esis. In contrast, most human exposures occur at low
doses (compared to the toxic dose in humans). To the ex-
tent that positive bioassay results are due to the effects
ofadministering the MTD, the 50% positive rate is prob-
ably anoverrepresentation oftheproportion ofall chem-
icals that are potentially carcinogenic to humans at low
doses.
Interspecies Comparisons
We have examined several aspects of interspecies ex-
trapolation in carcinogenesis. When the comparison be-
tween rats andmice excludes compounds composed solely
ofchlorine, carbon, hydrogen, and, optionally, oxygen, the
predictive value ofpositivity in each species for positiv-
ity inthe otheris 75% (i.e., the proportion ofcarcinogens
in one species detected in the other). Positive prediction
is slightly less accurate from mouse to rat when these
chlorinated compounds are included (70%). These results
between two closely related species provide some confi-
dence in the interspecies extrapolation. However, since
about half the test agents are carcinogenic in each spe-
cies, by chance alone we would expect a positive predic-
tive value between species of50%. The 75% result we ob-
tained would provide greater confidence in interspecies
extrapolation if, for example, only 5-10% of the test
agents were carcinogens. The overallpredictive values we
obtained with this large set of chemicals tested in both
species are similar to those reported by other research-
ers for small numbers oftest agents(9,13,14,18,23). Pur-
chase (15) earlier reported a slightly higher value (85%)
for a small number ofchemicals using different inclusion
rules (eg., route ofadministration) and different methods
to classify positivity. Further discussion ofthis literature
can be found in Haseman and Huff (14).
Our analysis has shown that mutagenicity and toxic
dose level are both associated with the prediction of car-
cinogenicity from one rodent species to another. Among
carcinogens, positive prediction between species tends to
be more accurate formutagens thanfornonmutagens, as
well asfor chemicals toxic atlow dosescomparedto those
that are toxic only at higher doses. Furthermore, there
is an association between the toxic level of a chemical and
mutagenicity. The explanation for these associations
amongtoxicity, mutagenicity, andpredictive value forthe
second species is not clear. Predictive values between spe-
cies maybe less accurate fornonmutagens than formuta-
gens because the carcinogenic response fornonmutagens
may depend more upon disposition ormetabolism, factors
that may vary more from species to species than does
damage to DNA. The relationship between mutagenicity
and toxic dose level may reflect a tendency ofmutagens
to be more toxic atlower doses because they are effective
at killing cells through damaging DNA.
In the standard bioassay, the goal is to administer the
test substance at a dose level thatis close to the MTD for
that substance, regardless of whether the chemical is
weak or strong. Onepossible explanation forthe observed
association betweenpredictive values andtoxicity is that
the MTD is less often achieved when the substance is
weak, either because it is underestimated or because a
higherdosewould constitutetoogreatapercentage ofthe
diet. Ifthis were true, then the administration of doses
belowthe MTD couldresultinfewerpositive experiments
and less accurate prediction between species for weaker
chemicals. Wereportedasimilarfindinginananalysis of
reproducibility of results in near-replicate experiments
where the same chemical was tested more than once by
the same route in the same strain, sex, and species (24).
For these chemicals, the administered dose levels were
generally higherfor the chemicals that had nonreprodu-
cible results than for those that were reproducible.
In our analysis ofthe predictive value ofpositivity for
the 10 most common target sites in rats and mice, we
showed that most sites are goodpredictors ofcarcinoge-
nicity at some site in the other species. The mouse liver
hasbeen asubject ofscientific debate due to itspredom-
inance as atarget organ and due to its high and variable
spontaneous tumorrate inthe B6C3F1 hybridusedinthe
NCI/NTP bioassays. Our result on the predictive value
ofthe mouse liver for positivity in the rat, 63% (74/117),
is somewhat lower than the 80% (41/52) reported earlier
by Tbmatis et al. (11), but similar to the 66% (56/85)
reported by Ward et al. (12). The chemicals and experi-
ments included in the Tbmatis et al. data set differ from
those in the CPDB; different inclusion rules were used
(e.g., 'Ibmatis et al. include experiments conductedby SC
injection), andthepresent analysis includes more chemi-
cals.
Our investigation indicates that the mouse liver is a
poorer predictor ofrat positivity than are other organs,
but that relatively few rodent carcinogens are single-site
mouse liver carcinogens (31/226, 14%). Overall, chemicals
that induce tumors only in the mouse liver are less often
genotoxicthanmouse livercarcinogens thatare alsoposi-
tive eitherin anothermouse organ orintherat; however,
there is no significant difference in the proportions that
are mutagenic when chlorinated chemicals are analyzed
separately from nonchlorinated chemicals. Chlorinated
compounds are more likely than other carcinogens to be
nonmutagenic and positive only in the mouse liver.
Our investigation has described differences between
chlorinated compounds and other chemicals withrespect
to predictivity, mutagenicity, and mouse liver carcinoge-
nicity. A high proportion ofthese compounds (74%) are
carcinogens, andthey are amongthe mostvisible rodent
carcinogensbecause oftheirwidespreadhumanexposure
orhighvolumeproduction. Many are commonsolvents or
pesticides thatareregulatedastoxic substances. Further
workis needed to understand the mechanism ofaction of
these carcinogensand howthismayaffectinterspeciesex-
trapolation.
The results presented in thispaper indicate thatpredic-
tion ofcarcinogenicity between rats and mice is correct
75% ofthe time and that predictive values vary accord-
ingto several factors includingmutagenicity ofthe com-
pound, chemical class, dose level at which a chemical is
toxic, and target organ. Inrodentbioassays, eventhough
nearly 50% ofthe chemicalstestpositive ineach species,
overall prediction to the otherrodent species is incorrect
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25% ofthe time. Additionally, considering both positive
and negative compounds, 25% are discordant between the
two rodent species. The practice ofextrapolating rodent
results to humans should be judged by this value. The
overall predictive value fromrats to humans orfrommice
to humans would be expected to be less than 75% since
rats andmice are closely related species. Tbbetterunder-
standthe validityofqualitative extrapolation betweenro-
dents andhumans, furtherworkis needed onmechanism
ofaction, endogenous damage to DNA, andthe extent to
which positivity in rodent bioassays may be affected by
administering the MTD, as well as on species differences
inmetabolism, phannacoldnetics, anddefenses suchasan-
ticarcinogens.
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